The industrial chemical bisphenol A (BPA) interferes with proliferative activity and development of steroidogenic capacity in rat Leydig cells.
The presence of bisphenol A (BPA) in consumer products has raised concerns about potential adverse effects on reproductive health. Testicular Leydig cells are the predominant source of the male sex steroid hormone testosterone, which supports the male phenotype. The present report describes the effects of developmental exposure of male rats to BPA by gavage of pregnant and lactating Long-Evans dams at 2.5 and 25 μg/kg body weight from Gestational Day 12 to Day 21 postpartum. This exposure paradigm stimulated Leydig cell division in the prepubertal period and increased Leydig cell numbers in the testes of adult male rats at 90 days. Observations from in vitro experiments confirmed that BPA acts directly as a mitogen in Leydig cells. However, BPA-induced proliferative activity in vivo is possibly mediated by several factors, such as 1) protein kinases (e.g., mitogen-activated protein kinases or MAPK), 2) growth factor receptors (e.g., insulin-like growth factor 1 receptor-beta and epidermal growth factor receptors), and 3) the Sertoli cell-secreted anti-Mullerian hormone (also called Mullerian inhibiting substance). On the other hand, BPA suppressed protein expression of the luteinizing hormone receptor (LHCGR) and the 17beta-hydroxysteroid dehydrogenase enzyme (HSD17B3), thereby decreasing androgen secretion by Leydig cells. We interpret these findings to mean that the likely impact of deficits in androgen secretion on serum androgen levels following developmental exposure to BPA is alleviated by increased Leydig cell numbers. Nevertheless, the present results reinforce the view that BPA causes biological effects at environmentally relevant exposure levels and its presence in consumer products potentially has implication for public health.
Department of Anatomy, Physiology, and Pharmacology, Auburn University, Auburn, Alabama 36849, USA.
Manjunatha K
MK
Nanjappa
Liz
L
Simon
Benson T
BT
Akingbemi
D015067:17-Hydroxysteroid Dehydrogenases / Q000096:biosynthesis; D000728:Androgens / Q000096:biosynthesis / Q000097:blood; D000818:Animals; D001559:Benzhydryl Compounds; D049109:Cell Proliferation / Q000187:drug effects*; D004968:Estrogens, Non-Steroidal / Q000633:toxicity*; D005260:Female; D007985:Leydig Cells / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D010636:Phenols / Q000633:toxicity*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000378:metabolism; D051381:Rats; D020318:Rats, Long-Evans; D011974:Receptors, LH / Q000096:biosynthesis; D013256:Steroids / Q000096:biosynthesis; D000098826:Bisphenol A Compounds
D015067:17-Hydroxysteroid Dehydrogenases; D000728:Androgens; D001559:Benzhydryl Compounds; D004968:Estrogens, Non-Steroidal; D010636:Phenols; D011974:Receptors, LH; D013256:Steroids; C044256:3 (or 17)-beta-hydroxysteroid dehydrogenase; C006780:bisphenol A; D000098826:Bisphenol A Compounds